Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes

Toxicology and Applied Pharmacology

Volumn 248, Issue 3, 2010, Pages 285-292

  De Luca, Chiara ^a   Scordo, Maria G ^b   Cesareo, Eleonora ^a   Pastore, Saveria ^a   Mariani, Serena ^a   Maiani, Gianluca ^a   Stancato, Andrea ^a   Loreti, Beatrice ^c   Valacchi, Giuseppe ^d,e   Lubrano, Carla ^c   Raskovic, Desanka ^a   De Padova, Luigia ^c   Genovesi, Giuseppe ^c   Korkina, Liudmila G ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e Kyung Hee University   (South Korea)

Author keywords

Catalase; CYP; Cytokine; Fatty acid; Gene polymorphism; GST

Indexed keywords

CATALASE; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A5; CYTOKINE; FATTY ACID; GAMMA INTERFERON; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; INTERLEUKIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; NITRITE; PLATELET DERIVED GROWTH FACTOR BB; SUPEROXIDE DISMUTASE; VASCULOTROPIN; XENOBIOTIC AGENT; CYTOCHROME P450;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ERYTHROCYTE MEMBRANE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ITALY; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CHEMICAL SENSITIVITY; OXIDATION REDUCTION REACTION; BLOOD; COMPARATIVE STUDY; DRUG EFFECTS; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADULT; AGED; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MULTIPLE CHEMICAL SENSITIVITY; OXIDATION-REDUCTION; POLYMORPHISM, GENETIC; XENOBIOTICS; YOUNG ADULT;

EID: 77953511911     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.04.017     Document Type: Article

References (60)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Bailer J., Witthöft M., Paul C., Bayerl C., Rist F. Evidence for overlap between idiopathic environmental intolerance and somatoform disorders. Psychosom. Med. 2005, 67:921-929.
3. Basu A., Hoerning A., Datta D., Edelbauer M., Stack M.P., Calzadilla K., Pal S., Briscoe D.M. Cutting edge: vascular endothelial growth factor-mediated signaling in human CD45RO+CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production. J. Immunol. 2010, 184:545-549.
4. Berg N.D., Rasmussen H.B., Linneberg A., Brasch-Andersen C., Fenger M., Dirksen A., Vesterhauge S., Werge T., Elberling J. Genetic susceptibility factors for multiple chemical sensitivity revisited. Int. J. Hyg. Environ. Health 2010, 213:131-139.
5. Bolt H.M., Kiesswetter E. Is multiple chemical sensitivity a clinically defined entity?. Toxicol. Lett. 2002, 128:99-106.
6. Bolt H.M., Their R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab. 2006, 7:613-628.
7. Bornschein S., Förstl H., Zilker T. Idiopathic environmental intolerances (formerly multiple chemical sensitivity) psychiatric perspectives. J. Intern. Med. 2001, 250:309-321.
8. Brown G.E., Silver G.M., Reiff J., Allen R.C., Fink M.P. Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J. Trauma 1999, 46:297-305.
9. Caress S.M., Steinemann A.C. A review of a two-phase population study of multiple chemical sensitivities. Environ. Health Perspect. 2003, 111:1490-1497.
10. 2 and inflammatory cytokine production. PLoS ONE 2008, 3:e3367.
11. Chun Y.J., Lee S., Yang S.A., Park S., Kim M.Y. Modulation of CYP3A4 expression by ceramide in human colon carcinoma HT-29 cells. Biochem. Biophys. Res. Commun. 2002, 298:687-692.
12. Crawford R.B., Holsapple M.P., Kaminski N.E. Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand. Mol. Pharmacol. 1997, 52:921-927.
13. Cullen M.R. Multiple chemical sensitivities: summary and directions for future investigators. Occup. Med. 1987, 2:801-804.
14. Deeva I., Mariani S., De Luca C., Pacifico V., Leoni L., Raskovic D., Kharaeva Z., Korkina L., Pastore S. Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease. Cytokine 2009, 49:163-170.
15. De Luca C., Filosa A., Grandinetti M., Maggio F., Lamba M., Passi S. Blood antioxidant status and urinary levels of catecholamine metabolites in β-thalassemia. Free Radic. Res. 1999, 30:453-462.
16. Fabig K.R. Das Multiple Chemikalien-Sensitivität-Syndrom (MCS). Können Fragebögen, IgE und SPECT zur Diagnostik beitragen?. Hamburger Ärzteblatt 2000, 12:600-603.
17. Funatake C.J., Marshall N.B., Steppan L.B., Mourich D.V., Kerkvliet N.I. Cutting edge: activation of the aryl hydrocarbon receptor by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin generates a population of CD4+CD25+ cells with characteristics of regulatory T cells. J. Immunol. 2005, 175:4184-4188.
18. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmoller J., Cascorbi I., Clapper M.L., Coutelle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh L.L., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le Marchand L., Lechner M.C., van Lieshout E.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Parl F.F., Pastorelli R., Persson I., Peters W.H., Rannug A., Rebbeck T., Risch A., Roelandt L., Romkes M., Ryberg D., Salagovic J., Schoket B., Seidegard J., Shields P.G., Sim E., Sinnet D., Strange R.C., Stucker I., Sugimura H., To-Figueras J., Vineis P., Yu M.C., Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 2001, 10:1239-1248.
19. Giovannoni G., Land J.M., Keir G., Thompson E.J., Heales S.J. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann. Clin. Biochem. 1997, 34:193-198.
20. Goldstone J.V., Hamdoun A., Cole B.J., Howard-Ashby M., Nebert D.W., Scally M., Dean M., Epel D., Hahn M.E., Stegeman J.J. The chemical defensome: environmental sensing and response genes in the Strongylocentrotus purpuratus genome. Dev. Biol. 2006, 300:366-384.
21. Haarmann-Stemmann T., Bothe H., Abel J. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem. Pharmacol. 2009, 77:508-520.
22. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
23. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45:51-88.
24. Jenkins C.M., Cedars A., Gross R.W. Eicosanoid signalling pathways in the heart. Cardiovasc. Res. 2009, 82:240-249.
25. Kerkvliet N.I. AHR-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharmacol. 2009, 77:746-760.
26. Kipen H.M., Fiedler N. Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge. Environ. Health Perspect. 2002, 110:597-599.
27. Korkina L., Scordo M.G., Deeva I., Cesareo E., De Luca C. The chemical defensive system in the pathobiology of idiopathic environment-associated diseases. Curr. Drug Metab. 2009, 10:914-931.
28. 2 and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients. Antioxid. Redox Signal 2010, 13(5):607-620.
29. Kreutzer R., Neutra R.R., Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am. J. Epidemiol. 1999, 150:1-12.
30. Liptrott N.J., Penny M., Bray P.G., Sathish J., Khoo S.H., Back D.J., Owen A. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br. J. Pharmacol. 2009, 156:497-508.
31. Marantos C., Mukaro V., Ferrante J., Hii C., Ferrante A. Inhibition of the lipopolysaccharide-induced stimulation of the members of the MAPK family in human monocytes/macrophages by 4-hydroxynonenal, a product of oxidized omega-6 fatty acids. Am. J. Pathol. 2008, 173(4):1057-1066.
32. Mattson M.P., Cheng A. Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 2006, 29:632-639.
33. McKeown-Eyssen G., Baines C., Cole D.E.C., Riley N., Tyndale R.F., Marshall L., Jazmaji V. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. Int. J. Epidemiol. 2004, 33:971-978.
34. Mirghani R.A., Sayi J., Aklillu E., Allqvist A., Jande M., Wennerholm A., Eriksen J., Herben V.M., Jones B.C., Gustafsson L.L., Bertilsson L. CYP3A5 genotype has significant effect on quintine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity compared to a Swedish population. Pharmacogenet. Genomics 2006, 16:637-645.
35. Miller C.S., Prihoda T.J. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol. Ind. Health 1999, 15:370-385.
36. Miller N.J., Rice-Evans C., Davies M.J. A new method for measuring antioxidant activity. Biochem. Soc. Trans. 1993, 21:95S.
37. Monaghan G., Ryan M., Seddon R., Hume R., Burchell B. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996, 347:578-581.
38. Nadin L., Butler A.M., Farrell G.C., Murray M. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha. Gastroenterology 1995, 109:198-205.
39. Paglia D.E., Valentine W.N. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
40. Pall M.L. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med. Hypotheses 2001, 57:139-145.
41. Pizzimenti S., Ferracin M., Sabbioni S., Toaldo C., Pettazzoni P., Dianzani M.U., Negrini M., Barrera G. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic. Biol. Med. 2009, 46:282-288.
42. Primavera A., Fustinoni S., Biroccio A., Ballerini S., Urbani A., Bernardini S., Federici G., Capucci E., Manno M., Lo Bello M. Glutathione transferases and glutathionylated hemoglobin in workers exposed to low doses of 1, 3-butadiene. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3004-3012.
43. Reed D.J., Babson J.R., Beatty P.W., Brodie A.E., Ellis W.W., Potter D.W. High performance liquid chromatography analysis of nanomole levels of glutathione disulphide and related thiols and disulphides. Anal. Biochem. 1980, 106:55-62.
44. Rodriguez-Sosa M., Elizondo G., Lopez-Duran R.M., Rivera I., Gonzalez F.J., Vega L. Over-production of IFN-gamma and IL-12 in AhR-null mice. FEBS Lett. 2005, 579:6403-6410.
45. Roy S., Khanna S., Nallu K., Hunt T.K., Sen C.K. Dermal wound healing is subject to redox control. Mol. Ther. 2006, 13:211-220.
46. Schnakenberg E., Fabig K.-R., Stanulla M., Strobl N., Lustig M., Fabig N., Schloot W. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes. Environ. Health 2007, 6:6. [Online 10 Feb. 2007 http://www.ehjournal.net/content/6/1/6]. 10.1186/1476-069X-6-6.
47. Scordo M.G., Caputi A.P., D'Arrigo C., Fava G., Spina E. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharm. Res. 2004, 50:195-200.
48. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
49. Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H., Doehmer J. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:3559-3563.
50. Strange R.C., Fryer A.A. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci. Publ. 1999, 148:231-249.
51. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497-500.
52. Tapner M., Liddle C., Goodwin B., George J., Farrell G.C. Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology 1996, 24:367-373.
53. Tinel M., Elkahwaji J., Robin M.A., Fardel N., Descatoire V., Haouzi D., Berson A., Pessayre D. Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. J. Pharm. Exp. Ther. 1999, 289:649-655.
54. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T.A. Activation of stress signalling pathways by the end product of lipid peroxidation. J. Biol. Chem. 1999, 274:2234-2242.
55. Wiesmüller G.A., Niggemann H., Weissbach W., Riley F., Maarouf Z., Dott W., Kunert H.J., Zerres K., Eggermann T., Blömeke B. Sequence variations in subjects with self-reported multiple chemical sensitivity (sMCS): a case-control study. J. Toxicol. Environ. Health A 2008, 71:786-794.
56. Willette A.A., Lubach G.R., Coe C.L. Environmental context differentially affects behavioral, leukocyte, cortisol, and interleukin-6 responses to low doses of endotoxin in the rhesus monkey. Brain Behav. Immun. 2007, 21:807-815.
57. Wilson C.B., Rowell E., Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 2009, 9:91-115.
58. Yadav S., Zajac E., Singhal S.S., Awasthi S. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters. Cancer Metastasis Rev. 2007, 26:59-69.
59. Yang Y., Yang Y., Xu Y., Lick S.D., Awashti Y.C., Boor P.J. Endothelial glutathione-S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappa B translocation. Toxicol. Appl. Pharmacol. 2008, 230:187-196.
60. Zhou C., Tabb M.M., Nelson E.L., Grün F., Verma S., Sadatrafiei A., Lin M., Mallick S., Forman B.M., Thummel K.E., Blumberg B. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J. Clin. Invest. 2006, 116:2280-2289.